University of Toronto, Canadian Hub for Health Intelligence & Innovation in Infectious Diseases (HI3)
About
University of Toronto (U of T) is the largest university in Canada boasting world-leading expertise in health and life sciences, artificial intelligence, and engineering. Together with its associated 14 members of the hospital Toronto Academic Health Science Network (TASHN), we are a #1 life sciences research Hub in Canada, #2 in number of clinical trials in North America with top 3 health research centre ranking in the world collectively garnering $2.2 billions in investment for life sciences start ups in the past 5 years. In 2022, this highly collaborative network contributed $89.6 billions to Canada's GDP and supported 200,000 jobs in the bio-economy.
UofT-led the Canadian Hub for Health Intelligence and Innovation in Infectious Diseases (HI3) [“hi cubed”], was established in March 2023 through the federal Canada Biomedical Research Fund (CBRF) program. The CBRF program enabled HI3 to further align the focus of our vibrant academic, industry, government, regulatory and health care programs to define the most urgent problems, find solutions, and deliver them to Canadians. The Hub also supports implementation of the Canadian Biomanufacturing and Life Sciences Strategy.
Our Vision: To unite research, healthcare and biomanufacturing through close multi-sectorial cooperation
Our Mission: Meet the diverse needs of Canadians by creating a sustainable ecosystem that can rapidly mobilize to create, translate, and manufacture interventions against infectious diseases
HI3 leverages the extensive collaborative interdisciplinary and multisectoral ecosystem of over 100 partners that represent Ontario academic institutions, world-renowned research hospitals, public and private sector that brings together our strengths into a consolidated pipeline. These partners bring tremendous scale-up and commercialization excellence to our network including talent training, robust translation and commercialization pipelines, generated and accessible health data and nimble market adoption as well as scale up biomanufacturing to deliver the therapeutic products to patients.
HI3 expertise lies in health intelligence, precision, intervention, bioprocess innovation, and talent training.
Representatives
Director, Strategy & Operations
University of Toronto, Canadian Hub for Health Intelligence & Innovation in Infectious Diseases (HI3)